# Hair disorders in cancer survivors

Source: https://onco.cc/key-papers/paper-freites-martinez-j-am-acad-dermatol/  
OnCo record `paper-freites-martinez-j-am-acad-dermatol` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Paper cited by one technology page, indexed on Europe PMC as PubMed record 29660423 and published in Journal of the American Academy of Dermatology; the citing page links this DOI, which is how the record was matched.

## Summary

With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy-induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.

Indexed on Europe PMC as PubMed record 29660423 (DOI 10.1016/j.jaad.2018.03.056). Matched by DOI alone: one technology page cites this DOI among its external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.

## Fields

- Kind: Key paper
- Last checked: 2026-09-22
- Tags: europepmc-ingest
- Journal: Journal of the American Academy of Dermatology
- Year: 2019
- DOI: 10.1016/j.jaad.2018.03.056
- Authors: Freites-Martinez A, Shapiro J, van den Hurk C, et al.
- What it means: One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
- Caveats: Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper.

## Sources

- J Am Acad Dermatol 2019: https://doi.org/10.1016/j.jaad.2018.03.056
- PubMed: https://pubmed.ncbi.nlm.nih.gov/29660423/
- Europe PMC: https://europepmc.org/article/MED/29660423

## Connected records

- technologies: [Minoxidil for persistent chemotherapy- and endocrine-therapy hair loss](https://onco.cc/technologies/minoxidil-chemotherapy-alopecia/)

---
JSON: https://onco.cc/api/v1/entities/paper-freites-martinez-j-am-acad-dermatol.json